Liddie syndrome: An autosomal dominant form of human hypertension

Kidney International

Volumn 53, Issue 1, 1998, Pages 18-24

  Warnock, David G ^a,b  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b University of Alabama at Birmingham   (United States)

Author keywords

Autosomal dominant form of hypertension; Hypertension; Liddie syndrome; Pseudoaldosteronism

Indexed keywords

AMILORIDE; ANTIHYPERTENSIVE AGENT; POTASSIUM SPARING DIURETIC AGENT; SPIRONOLACTONE; TRIAMTERENE; RENIN; SODIUM CHANNEL;

AUTOSOMAL DOMINANT DISORDER; DRUG CHOICE; GENE MUTATION; GENETIC ANALYSIS; GENETIC LINKAGE; HUMAN; HYPERTENSION; LIDDLE SYNDROME; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SODIUM RESTRICTION; AMINO ACID SEQUENCE; BLOOD; GENETICS; MOLECULAR GENETICS; MUTATION; SYNDROME;

AMINO ACID SEQUENCE; HUMANS; HYPERTENSION; LINKAGE (GENETICS); MOLECULAR SEQUENCE DATA; MUTATION; RENIN; SODIUM CHANNELS; SYNDROME;

EID: 0031594450     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1998.00728.x     Document Type: Article

References (58)

1. LIDDLE GW, BLEDSOE T, COPPAGE WS: A familial renal disorder simulating primary aldosteronism but with negligible aldosterone secretion. Trans Am Assoc Phys 76:199-213, 1963
2. BOTERO-VELEZ M, CURTIS JJ, WARNOCK DG: Brief report: Liddle's syndrome revisited. N Engl J Med 330:178-181, 1994
3. NOBLINS M, KLEINKNECHT D, DOMMERGUES JP, NAZARET C, GARAY RP, JULLIEN M, GUILLOT M, FRIES D, CHARPENTIER B: Syndrome de Liddle (ou pseudo-hyperaldostéronism): Evoultion à long terme et étude des flux potassiques érythrocytaires dans 4 observations. Arch French Pediatrics 49:685-691, 1992
4. LIFTON RP: Molecular genetics of human blood pressure variation. Science 272:676-680, 1996
5. LIFTON RP, DLUHY RG, POWERS M, RICH GM, GUTKIN M, FALLO F, GILL JRJ, ET AL: Hereditary hypertension caused by chimeric gene duplications and extopic expression of aldosterone synthase. Nature Genet 2:66-74, 1992
6. SHIMKETS RA, WARNOCK DG, BOSITIS CM, NELSON-WILLIAMS C, HANSSON JH, SCHAMBELAN M, GILL JRJ, ULICK S, MILORA RV, FINDLING JW, CANESSA CM, ROSSIER BC, LIFTON RP: Liddle's syndrome: Heritable human hypertension caused by mutations in the β subunit of the epithelial sodium channel. Cell 79:407-414, 1994
7. MUNE T, ROGERSON FM, NIKKILA H, AGARWAL AK, WHITE PC: Human hypertension caused by mutations in the kidney isozyme of 11 beta-hydroxysteroid dehydrogenase. Nature Genet 10:394-399, 1995
8. TAKEUCHI K, ABE K, SATO M, YASUJIMA M, OMATA K, MURAKAMI O, YOSHINAGA K: Plasma aldosterone level in a female case of pseudohyperaldosteronism (Liddle's syndrome). Endocrinol Japan 36:167-173, 1989
9. OHNO F, HARADA H, KOMATSU K, SAIJO K, MIYOSHI K: Two cases of pseudoaldosteronism (Liddle's Syndrome) in siblings. Endocrin Japonica 22:163-167, 1975
10. TAMURA H, SCHILD L, ENOMOTO N, MATSUI N, MARUMO F, ROSSIER BC, SESAKI S: Liddle disease caused by a missense mutation of β subunit of the epithilial sodium channel gene. J Clin Invest 97:1780-1784, 1996
11. RODRIGUEZ JA, BIGLIERI EG, SCHAMBELAN M: Pseudohyperaldosteronism with renal tubular resistance to mineralocorticoid hormones. Trans Assoc Am Phys 94:172-182, 1981
12. GADALLAH MF, ABREO K, WORK J: Liddle's syndrome: An underrecognized entity; a report of four cases including the first report in black individuals. Am J Kidney Dis 25:424-927, 1995
13. CANESSA CM, SCHILD L, BUELL G, THORENS B, GAUTSCHIL Y, HORISBERGER J-D, ROSSIER BC: The amiloride-sensitive epithelial sodium channel is made of three homologous subunits. Nature 367: 463-467, 1994
14. CANESSA CM, HORISBERGER J-D, ROSSIER BC: Epithelial sodium channel related to proteins involved in neurodegeneration. Nature 361:467-470, 1993
15. ROSSIER BC: Cum grano salis: The epithelial sodium channel and the control of blood pressure. J Am Soc Nephrol 8:980-992, 1997
16. DRISCOLL M, CHALFIE M: The mec-4 gene is a member of a family of Caenorhabditis elegans genes that can mutate to induce neuronal degeneration. Nature 349:588-593, 1991
17. HUANG K, CHALFIE M: Gene interactions affecting mechanosensory transduction in Caenorhabditis elegans. Nature 367:467-470, 1994
18. HONG K, DRISCOLL M: A transmembrane domain of the putative channel subunit MEC-4 influences mechanotransduction and neurodegeneration in C. elegans. Nature 367:470-473, 1994
19. HANSSON JH, NELSON-WILLIAMS C, SUZUKI H, SCHILD L, SHIMKETS R, LU Y, CANESSA C, IWASAKI T, ROSSIER B, LIFTON R: Hypertension caused by a truncated epithelial sodium channel γ subunit: Genetic heterogeneity of Liddle syndrome. Nature Genet 11:76-82, 1995
20. SCHILD L, LU Y, GAUTSCHI I, SCHNEEBERGER E, LIFTON RP, ROSSIER BC: Identification of a PY motif in the epithelial Na channel subunits as a target sequence for mutations causing channel activation found in Liddle's syndrome. EMBO J 15:2381-2387, 1996
21. HANSSON JH, SCHILD L, LU Y, WILSON TA, GAUTSCHI I, SHIMKETS R, NELSON-WILLIAMS C, ROSSIER B, LIFTON R: A de novo missense mutation of the β subunit of the epithelial sodium channel causes hypertension and Liddle syndrome, identifying a proline-rich segment critical for regulation of channel activity. Proc Natl Acad Sci USA 92:11495-11499, 1995
22. + channel deleted in Liddle's syndrome. EMBO J 15:2371-2380, 1996
23. + channel (αrENaC) mediates its localization at the apical membrane. EMBO J 13:4440-4450, 1994
24. FIRSOV D, SCHILD L, GAUTSCHI I, MÉRILLAT A-M, SCHNEEBERGER E, ROSSIER BC: Cell surface expression of the epithelial Na channel and a mutatant causing Liddle syndrome: A quantitative approach. (abstract) Proc Natl Acad Sci USA 93:15370-15375, 1996
25. + channel are differently regulated by aldosterone. J Biol Chem 269:13736-13739, 1994
26. + channel. Cell 83:969-978, 1995
27. LIN C, WORRELL RT, KIEBER-EMMONS T, CANESSA CM, ROSSIER BC, EATON DC, KLEYMAN TR: Mutagenesis of a putative amiloride-binding site of the epithelial Na channel. (abstract) J Am Soc Nephrol 5:291A, 1994
28. SCHILD L, SCHNEEBERGER E, GAUTSCHI I, FIRSOV D: Identification of amino acid residues in the α, βand γ subunits of the epithelial sodium channel (ENaC) involved in amiloride block and ion permeation. J Gen Physiol 109:15-26, 1997
29. CHANG SS, GRUNDER S, HANUKOGLU A, ROSLER A, MATHEW PM, HANUKOGLU I, SCHILD L, LU Y, SHIMKETS RA, NELSON-WILLIAMS C, ROSSIER BC, LIFTON RP: Mutations in subunits of the epithelial sodium channel cause salt wasting with hyperkalaemic acidosis. pseudohypoaldosteronism type 1. Nature Genet 12:248-253, 1996
30. GARDNER JD, LAPEY A, SIMOPOULOUS AP, BRAVO EL: Abnormal membrane sodium transport in Liddle's syndrome. J Clin Invest 50:2253-2258, 1971
31. WARNOCK DG, BUBIEN JK: Liddle syndrome: Clinical and cellular abnormalities. Hosp Pract 29:95-105, 1994
32. BUBIEN JK, WARNOCK DG: Amiloride-sensitive sodium conductance in human B lymphoid cells. Am J Physiol (Cell Physiol) 265:C1175-C1183, 1993
33. BUBIEN JK, JOPE RS, WARNOCK DG: G-proteins modulate amiloride-sensitive sodium channels. J Biol Chem 269:17780-17783, 1994
34. OH Y, WARNOCK DG: Expression of the amiloride-sensitive sodum channel β subunit gene in human B lymphocytes. J Am Soc Nephrol 8:126-129, 1997
35. WALDMAN R, CHAMPIGNY G, VOILLEY N, LAURITZEN I, LAZDUNSKI M: The mammalian degenerin MDEG, an amiloride-sensitive cation channel activated by mutations causing neurodegeneration in Caenorhabditis elegans. J Biol Chem 271:10433-10436, 1996
36. + channel. J Biol Chem 270:27411-27414, 1995
37. + channel δ isoform to chromosome 1p36.3-p36.2. Genomics 34:262-263, 1996
38. + channel. J Biol Chem 271:7879-7882, 1996
39. + channel regulation. Kidney Int 48:970-984, 1995
40. SCHILD L, CANESSA CM, SHIMKETS RA, GAUTSCHI I, LIFTON RP, ROSSIER BC: A mutation in the epithelial sodium channel causing Liddle disease increases channel activity in the Xenopus laevis oocyte expression sytem. Proc Natl Acad Sci USA 92:5699-5703, 1995
41. + channels in Liddle's disease. Am J Physiol (Cell Physiol) 270:C214-C223, 1996
42. + channels by β-subunit mutation. Am J Physiol (Cell Physiol) 270:C208-C213, 1996
43. SAXENA S, QUICK M, WARNOCK DG: Role of PKA and PKC in the regulation of amiloride-sensitive epithelial sodium channels expressed in Xenopus oocytes. (abstract) J Invest Med 45:43, 1997
44. DOSTMANN WR, TAYLOR SS, GENIESER HG, JASTORFF B, DOKELAND SO, OGREID D: Probing the cyclic nucleotide binding sites of cAMP-dependent protein kinases I and II with analogues of adenosine 3′,5′-cyclic phosphorothioates. J Biol Chem 265:10484-10491, 1990
45. BUBIEN JK, JEUNEMAÎTRE X, CORVOL P, WARNOCK DG: Functional differences due to truncations of the β subunit of the amiloride-sensitive sodium channel. (abstract) J Am Soc Nephrol 7:1277, 1996
46. SU YR, RUTKOWSKI MP, KLANKE CA, WU X, CUI Y, PUN RYK, CARTER V, REIF M, MENON AG: A novel variant of the β-subunit of the amiloride-sensitive sodium channel in African Americans. J Am Soc Nephrol 7:2543-2549, 1996
47. + transport. J Am Soc Nephrol 7:2490-2494, 1996
48. LIFTON RP, DIUHY RG, POWERS M, RICH G, COOK S, ULICK S, LALOUEL J-M: A chimaeric 11 β-hydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension. Nature 355:262-265, 1992
49. PASCOE L, JEUNEMAITRE X, LEBRETHON M-C, CURNOW KM, GOMEZ-SANCHEZ CE, GASC J-M, SAEZ JM, CORVOL P: Glucocorticoid-suppressible hyperaldosteronism and adrenal tumors occurring in a single French pedigree. J Clin Invest 96:2236-2246, 1995
50. RICH G, ULICK S, COOK S, WANG J, LIFTON R, DLUHY R: Glucocorticoid-remediable aldosteronism in a large kindred: Clinical spectrum and diagnosis using a characteristic biochemical phenotype. Ann Int Med 116:813-820, 1992
51. WILSON RC, KROZOWSKI ZS, LI K, OBEYESEKERE VR, RAZZAGHY-AZAR M, HARBISON MD, WEI JQ, SHACKLETON CH, FUNDER JW, NEW MI: A mutation in the HSD11B2 gene in a family with apparent mineralocorticoid excess. J Clin Endocrin Metab 80:2263-2266, 1995
52. STEWART PM, CORRIE JET, SHACKLETON CHL, EDWARDS CRW: Syndrome of apparent mineralocorticoid excess: A defect in the cortisol-cortisone shuttle. J Clin Invest 82:340-349, 1988
53. YIU VWY, DLUHY RP, LIFTON RP, GUAY-WOODFORD LM: Low peripheral plasma renin activity (PRA) as a critical screening indicator of glucocorticoid remediable hypertension. Pediatr Nephrol (in press)
54. GRIFFING GT, WILSON TE, MELBY JC: Alterations in aldosterone secretion and metabolism in low renin hypertension. J Clin Endocrinol Metab 71:1454-1460, 1990
55. WARNOCK DG, BUBIEN JK: Liddle's syndrome: A public health menace? Am J Kidney Dis 25:924-927, 1995
56. SMITH PR, BENOS DJ: Epithelial Na+ channels. Ann Rev Physiol 53:509-530, 1991
57. BIGLIERI EG: Primary aldosteronism. Curr Ther Endocrinol Metabol 5:152-155, 1994
58. SHACKLETON CH: Mass spectrometry in the diagnosis of steroid-related disorders and in hypertension research. J Steroid Biochem Molec Biol 45:127-140, 1993